Concepedia
Statistics
Publications
24
Citations
2.8K
H-Index
19
Active since
2004
Affiliations
Bristol-Myers Squibb (Switzerland)(Current)
St George's Hospital
St George's, University of London
The University of Texas MD Anderson Cancer Center
Janssen (United States)
J. Blake Bartlett is an author at Bristol-Myers Squibb (Switzerland) specializing in medicine, pharmacology, and oncology.
Publications per year
2004–2023
Lenalidomide Enhances Natural Killer Cell and Monocyte-Mediated Antibody-Dependent Cellular Cytotoxicity of Rituximab-Treated CD20+ Tumor Cells
Lei Wu, Mary Adams, Troy Carter et al. · Clinical Cancer Research · 2008 · 434 citations · Full text
Life Sciences, Immunology, Pharmacology +17
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
Christine Galustian, B Meyer, Marie‐Christine Labarthe et al. · Cancer Immunology Immunotherapy · 2008 · 387 citations · Full text
Medicine, Oncology, Pharmacology +13
Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma
Stephen Schey, Paul Fields, J. Blake Bartlett et al. · Journal of Clinical Oncology · 2004 · 313 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro
Keith Dredge, Rebecca Horsfall, Simon P. Robinson et al. · Microvascular Research · 2005 · 268 citations
The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions
Ling Lu, Faribourz Payvandi, Lei Wu et al. · Microvascular Research · 2008 · 224 citations
Medicine, Oncology, Pharmacology +17
1–5 of 24